Post job

Icosavax overview

Industry
Biotechnology
Revenue
Headquarters
Employees
34
Founded in
Website
Organization type
Public
Social media
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. tHEY were founded on breakthrough computationally-designed virus-like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington.
Based in Seattle, WA, Icosavax is a small health care company with only 34 employees and an annual revenue of $582,000.

Icosavax's mission statement

Icosavax was formed in 2017 to advance the breakthrough VLP technology from the institute for protein design at the university of washington with the goal to discover, develop, and commercialize vaccines against infectious diseases.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Icosavax employee reviews

Be the first to review!

Do you work at Icosavax?

Help job seekers learn about working at Icosavax

On this page

Be the first to review Icosavax

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Icosavax?

The team at Icosavax

  • The founders of Icosavax are Adam K. Simpson, David Baker Ph.d and Christian Mandl.
  • The key people at Icosavax are Adam K. Simpson, David Baker Ph.d and Christian Mandl.
Key people
Adam K. Simpson
David Baker Ph.d
Christian Mandl

Icosavax rankings

Icosavax is ranked #71 on the Best Health Care companies to work for in Washington list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Rate Icosavax's fairness in compensating employees.

Zippia waving zebra

Do you work at Icosavax?

Does Icosavax actively promote diversity and inclusion?

Icosavax financial performance

9.7
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Icosavax currently has 582.0K in revenue. Icosavax's most recent quarter produced 582.0k (q1'2022).

Icosavax annual revenue

$8M
$6M
$5M
$3M
$2M
$0
2020
2021
2022

Are you an executive, HR leader, or brand manager at Icosavax?

Claiming and updating your company profile on Zippia is free and easy.

Icosavax FAQs

Search for jobs

Zippia gives an in-depth look into the details of Icosavax, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Icosavax. The employee data is based on information from people who have self-reported their past or current employments at Icosavax. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Icosavax. The data presented on this page does not represent the view of Icosavax and its employees or that of Zippia.

Icosavax may also be known as or be related to ICOSAVAX, INC., Icosavax, Icosavax Inc and Icosavax, Inc.